Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Sticky breakthrough? new adhesive for brain monitor tested

NCT ID NCT05111847

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested the safety and skin-friendliness of new adhesive baseplates for the UNEEG Episight recorder, a device that records brain waves. Thirty-four healthy adults wore different baseplates behind their ears for about 17-18 days each. Researchers measured skin health and checked for any skin reactions to see if the adhesives are safe for repeated use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Baseplates with biocompatible adhesives (device)
What this could lead to
If successful, this could lead to a more comfortable and reliable way to attach EEG recorders for long-term brain monitoring.
What could go wrong
This is a small, early-stage study in healthy people, so results may not apply to patients. Skin reactions or discomfort from the adhesives are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

34 people

The number who actually took part.

Started

Oct 2021

Finished

Jun 2022

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 120 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Informed consent obtained, and letter of authority signed before any study related activities * Are at least 18 years of age and have full legal capacity * Healthy skin behind the ear Exclusion Criteria: * Pregnant or breastfeeding * Known allergic responses to the adhesives * Treatment with corticosteroids, either as a cream in the area behind the ear or systemically (tablet or injection) within the last month * Subject is unable or does not have the necessary assistance to properly operate the device system

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy subjects are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dermato-Venerologisk Afdeling og Videncenter for Sårheling, Bispebjerg Hospital

    København NV, 2400, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.